(S (NP-SBJ-43 Kappa/NN B/NN binding/NN proteins/NNS) (VP are/VBP (ADVP constitutively/RB) (VP expressed/VBN (NP *-43/-NONE-) (PP in/IN (NP an/DT IL-2/NN autocrine/NN human/JJ T/NN cell/NN line/NN)))) ./.)
(S (NP-SBJ-44 (NP-COOD (NP The/DT IL-2/NN) and/CC (NP the/DT IL-2-R/NN alpha/NN)) genes/NNS) (VP are/VBP (VP both/DT (VP expressed/VBN (NP *-44/-NONE-) (ADVP transiently/RB) (PP in/IN (NP normal/JJ T/NN lymphocytes/NNS)) (PP-TMP after/IN (NP (NP-COOD (NP Ag/NN) or/CC (NP mitogen/NN)) activation/NN))))) ./.)
(S-COOD (S (PP In/IN (NP contrast/NN)) ,/, (NP-SBJ (NP the/DT human/JJ T/NN cell/NN line/NN) ,/, (NP IARC/NN 301/CD) ,/,) (VP expresses/VBZ (NP these/DT two/CD genes/NNS) (ADVP constitutively/RB))) and/CC (S (NP-SBJ we/PRP) (VP have/VBP (ADVP-TMP previously/RB) (VP demonstrated/VBN (SBAR that/IN (S (NP-SBJ its/PRP$ growth/NN) (VP depends/VBZ (PP on/IN (NP (NP the/DT autocrine/JJ production/NN) (PP of/IN (NP-COOD (NP this/DT T/NN cell/NN growth/NN factor/NN) and/CC (NP high/JJ affinity/NN IL-2R/NN))))))))))) ./.)
(S (S-ADV (NP-SBJ-46 *-45/-NONE-) (VP To/TO (VP dissect/VB (NP (NP the/DT molecular/JJ basis/NN) (PP for/IN (NP (NP the/DT unusual/JJ persistent/JJ expression/NN) (PP of/IN (NP (NP the/DT (NP-COOD (NP IL-2/NN) and/CC (NP IL-2-R/NN alpha/NN)) genes/NNS) (PP in/IN (NP these/DT IARC/NN 301/CD T/NN cells/NNS)))))))))) ,/, (NP-SBJ-45 we/PRP) (VP have/VBP (VP analyzed/VBN (NP (NP the/DT interactions/NNS) (PP of/IN (NP (ADJP constitutively/RB expressed/VBN) nuclear/JJ proteins/NNS)) (PP with/IN (NP (NP the/DT 5'/JJ flanking/JJ regions/NNS) (PP of/IN (NP the/DT (NP-COOD (NP IL-2/NN) and/CC (NP IL-2-R/NN alpha/NN)) genes/NNS))))) (S (NP-SBJ *-46/-NONE-) (VP using/VBG (NP (NP-COOD both/DT (NP DNase/NN I/CD footprinting/NN) and/CC (NP gel/NN retardation/NN)) techniques/NNS))))) ./.)
(S (NP-SBJ We/PRP) (VP have/VBP (VP found/VBN (SBAR that/IN (S (NP-SBJ-48 (NP a/DT region/NN) (PP in/IN (NP both/DT genes/NNS)) (PRN -LRB-/-LRB- (NP-COOD (NP (NP-COOD (NP -276/CD) to/TO (NP -250/CD)) (PP for/IN (NP IL-2-R/NN alpha/NN))) and/CC (NP (NP-COOD (NP -203/CD) to/TO (NP -183/CD)) (PP for/IN (NP IL-2/NN)))) -RRB-/-RRB-) ,/, (SBAR (WHNP-47 which/WDT) (S (NP-SBJ *T*-47/-NONE-) (VP corresponds/VBZ (PP to/TO (NP a/DT kappa/NN B/NN enhancer/NN element/NN))))) ,/,) (VP is/VBZ (ADVP specifically/RB) (VP protected/VBN (NP *-48/-NONE-) (PP by/IN (NP-LGS (NP nuclear/JJ proteins/NNS) (PP from/IN (NP IARC/NN 301/CD)))))))))) ./.)
(S (PP In/IN agreement/NN with/IN (NP this/DT finding/NN)) ,/, (NP-SBJ both/CC the/DT (NP-COOD (NP IL-2/NN) and/CC (NP IL-2-R/NN alpha/NN)) promoters/NNS) (VP are/VBP (ADJP-PRD active/JJ) (PP in/IN (NP (NP transient/JJ transfection/NN assays/NNS) (PP in/IN (NP IARC/NN 301/CD cells/NNS))))) ./.)
(S (PP In/IN (NP contrast/NN)) ,/, (NP-SBJ (NP mutation/NN) (PP of/IN (NP the/DT kappa/NN B/NN enhancer/NN))) (VP results/VBZ (PP in/IN (NP (NP (ADJP markedly/RB attenuated/VBN) activities/NNS) (PP of/IN (NP both/DT promoters/NNS))))) ./.)
(S (NP-SBJ-49 (NP (NP Two/CD proteins/NNS) (VP binding/VBG (NP the/DT kappa/NN B/NN sequence/NN))) ,/, (NP-COOD (NP NF-kappa/NN B/NN) and/CC (NP KBF1/NN)) ,/,) (VP are/VBP (ADVP constitutively/RB) (VP-COOD (VP expressed/VBN (NP-50 *-49/-NONE-) (PP in/IN (NP IARC/NN 301/CD nuclei/NNS))) and/CC (VP induced/VBN (NP *-50/-NONE-) (PP by/IN (NP-LGS-COOD (NP PMA/NN) and/CC (NP PHA/NN))) (PP in/IN (NP Jurkat/NN))))) ./.)
(S (NP-SBJ They/PRP) (VP bind/VBP (PP to/TO (NP (NP the/DT kappa/NN B/NN motifs/NNS) (PP with/IN (NP different/JJ relative/JJ affinities/NNS)) (SBAR (WHNP-51 that/WDT) (S (NP-SBJ *T*-51/-NONE-) (VP may/MD (VP reflect/VB (NP (NP their/PRP$ different/JJ contribution/NN) (PP in/IN (NP (NP the/DT expression/NN) (PP of/IN (NP various/JJ promoters/NNS)))))))))))) ./.)
